Therefore, we reasoned that use of adoptive transfer of tumor-specific CTLs to produce IFN-γ and TNFα locally in the tumor microenvironment in combination with TRAIL protein/mAb therapy should effectively induce colon carcinoma cell apoptosis, and thereby suppressing colon cancer metastasis. Here, IFNG is linked to colon carcinoma.